Living with Pancreatic Cancer
738 articles

Can I exercise? How can I cope with stress and anxiety? Learn more here.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
Immunotherapy to Attack a Common Pancreatic Cancer Mutation
Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Let’s Win in a Spectrum News NY1 Report for Pancreatic Cancer Awareness Month
Cindy Gavin and Dr. Allyson Ocean appeared in a Spectrum News NY1 report on a pancreatic cancer patient, for Pancreatic Cancer Awareness Month.
Presurgical Treatment for Pancreatic Cancer That Is Removable
A clinical trial looks at immunotherapy plus vitamin D plus standard chemotherapy before surgery to remove pancreatic cancer.